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Abstract
Cell surface carbohydrates play an important role in virus entry and intracellular trafficking. Bovine Adeno-Associated Virus
(BAAV) uses plasma membrane gangliosides for transduction and infection. In addition, independent of the infectious
pathway, BAAV also has the ability to pass through barrier epithelia and endothelia using a transcytosis pathway dependent
upon the presence of cell surface carbohydrates. Thus, in order to better define the carbohydrate interactions that are
necessary for BAAV infection or transcytosis, a glycan microarray composed of both natural and synthetic carbohydrates
was probed with HA-tagged BAAV particles. This identified chitotriose, a trimer of b-1-4-linked N-acetyl glucosamine, as
having an interaction with BAAV. Competition experiments showed that the BAAV interaction with this carbohydrate is not
necessary for infection but is instead important in the transcytosis pathway. The b-1-4-linked N-acetyl glucosamine
modification has been reported on gp96, a glycoprotein involved in the transcytosis of bacteria and toxins. Significantly,
immunoprecipitation and competition experiments with an anti-gp96 antibody and a soluble form of gp96, respectively,
showed this glycoprotein can also interact with BAAV to serve as a receptor for its transcytosis.
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Introduction
The initial interaction between a virus and the cell surface is
critical for determining the fate of the virus. While some
interactions will lead to entry and infection of the cells, others
will lead to the destruction of the virus in the cytosol [1–3].
Carbohydrate interactions play an important role in the life cycle
of viruses. In addition to serving as a point of attachment for the
virus on the cell surface, carbohydrates on viral proteins are also
important in intracellular trafficking [4].
Adeno-associated viruses (AAVs) have been isolated from a wide
variety of species and are reported to bind a diverse array of cell
surface carbohydrates including heparan sulfate proteoglycans, N-
and O-linked sialyated glycans, and glycoshingolipids (reviewed in
[5]). While the majority of interactions between AAV and
carbohydrates have been associated with cell binding, virus entry,
and infection, it is possible that they are also involved in other
aspects of the virus lifecycle.
Previous work from our group with an AAV isolated from a
stock of bovine adenovirus, termed bovine AAV (BAAV) [6]
demonstrated that this virus did not require cell surface proteins
for entry but instead used gangliosides for cell infection and
transduction [7]. This tropism resulted in gene transfer vectors
based on BAAV having a unique tropism compared with current
AAV vectors and the ability to transduce cells in the inner ear
[8–10]. In addition, this and other AAV serotypes, for example
AAV4 and AAV5, have the ability to pass through barrier
epithelia and endothelia using transcytosis via a pathway
independent of that used for infection [11]. Our experiments with
BAAV, AAV4, and AAV5 suggested that this process is rapid as
well as serotype and cell-type specific and can be blocked by
neutralizing antibodies, temperature, or chemical inhibitors of
transcytosis. We observed that depending on the cell type and
vector, as much as 3 to 15% of the vector that binds to the cell
surface will transcytosis through a permissive barrier cell model
over 24 hrs [11]. Furthermore, competition experiments with
lectins suggested the involvement of cell surface carbohydrates in
this process [11]. Interestingly, particles isolated following apical-
to-basolateral transcytosis still have their genomes encapsulated
and can transduce permissive cell lines in vitro [11].
Transcytosis has been reported for a number of macromolecules
as well as pathogens such as bacteria and viruses. At its most basic
level, transcytosis is the movement of macromolecules from one
side of a cell to the other and can occur by a variety of mechanisms
[12]. For HIV transcytosis, cell surface galactosyl-ceramides have
been proposed as a receptor for this pathway [13]. For other
pathogens such as S. pneumoniae, translocation across a barrier layer
via the poly(IgA) receptor [14,15] has been proposed. As described
above, transcytosis activity has been demonstrated in BAAV,
AAV4, AAV5 and has been proposed to occur in 2 others; AAV8
and AAV9 [11,16–19]. However, little is known regarding the
mechanism of AAV transcytosis. In order to better define the
carbohydrate interactions that are necessary for BAAV transduc-
tion or transcytosis we probed a glycan microarray composed of
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particles tagged with an antigenic peptide from the influenza
hemagglutinin (HA) protein (HA-BAAV particles). This analysis
identified an interaction with chitotriose, a trimer of b-1-4 linked
N-acetyl glucosamine (GlcNAc). This interaction was specific for
BAAV and was not seen with an HA-tagged AAV4, which has a
high amino acid sequence homology to BAAV as well as a distinct
but overlapping transduction and transcytosis activity [6,11].
Competition experiments showed that the interaction of BAAV
with this carbohydrate is not necessary for transduction but is
important in the transcytosis pathway. Furthermore, additional
experiments showed that gp96, a b-1-4 linked N-acetyl glucos-
amine containing membrane glycoprotein, involved in the
transcytosis of bacteria and toxins in epithelial and endothelial
barriers, can serve as a receptor for BAAV transcytosis.
Results
BAAV Binds Chitotriose When Screened on a Glycan
Microarray
In order to better define the carbohydrate interactions that are
necessary for BAAV’s life cycle we probed a glycan microarray
composed of carbohydrates commonly found on the cell surface. The
array is available through the Consortium for Functional Glycomics
(CFG) and currently contains over 400 sialyated and nonsialyated
glycans with different linkages and modifications and has been
previously useful in characterizing AAV virus particle:carbohydrate
interactions [20]. Purified BAAV vector genetically tagged with an HA
epitope after amino acid 137 of VP1 and within the VP2 orf, a
modification which has previously been shown not to effect the
transduction activity of AAV2 [21,22], was used to probe the printed
slide (PA V2 http://www.functionalglycomics.org/static/consortium/
resources/resourcecoreh8.shtml). The bound virus was detected using
an FITC conjugated anti-HA antibody. The full summary of the
microarray data is available at NCBI accession number GSE17443.
The highest interaction was seen with glycan #173, GlcNAcb1-
4GlcNAcb1-4GlcNAcb–Sp8 or chitotriose (Fig. 1). Although signifi-
cantly lower, BAAV vectors also showed weak affinity for glycan #110
Gala1-4Galb1-4GlcNAcb–Sp8 or the P1 blood group antigen. The
same array probed with an HA tagged rAAV4 particles under the
same conditions did not show these interactions (data not shown).
Chitotriose Inhibits BAAV Transcytosis but Not
Transduction
Chitotriose is a trimer of b-1-4-linked N-acetyl glucosamine
units and can competitively inhibit lysozyme C [23]. Multimers of
N-acetyl glucosamine are found as a post-translational modifica-
tion on proteins and competition experiments with chitotriose can
block the transcytosis of pathogens [24,25].
In order to understand the role of the chitotriose carbohydrate
in the life cycle of BAAV, cos cell transduction by BAAV vector
virions encoding GFP was analyzed following pre-incubation with
this glycan. The addition of chitotriose did not inhibit BAAV
transduction of the cos cells, but rather slightly increased (10%)
Figure 1. BAAV glycan binding on a glycan microarray. A printed glycan array slide containing 264 glycans (PA V2) was screened to identify
stable BAAV carbohydrate interactions. The plot shows the average relative fluorescence (RFU) with the standard error measurement (SEM) for each
glycan versus glycan number. The values for the top two hits (#173, GlcNAcb1-4GlcNAcb1-4GlcNAcb–Sp8 or chitotriose, and # 110 Gala1-4Galb1-
4GlcNAcb–Sp8 or the P1 blood group antigen) are listed below the figure.
doi:10.1371/journal.pone.0009336.g001
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increased (50%) in the presence of chitotriose (Fig. 2A). Primary
human airway epithelia (HAE) and MDCK1 cells have been
shown to be permissive to both BAAV and AAV4 transcytosis
(approx. 0.2–1% of total input vector will transcytose through the
cells in 3 hrs [11]) and form a stable polarized monolayer that
develops a trans epithelial resistance (TER) [11]. In contrast to the
transduction assay, the addition of chitotriose blocked the
transcytosis of BAAV when the virus was pre-incubated with the
glycan prior to application to the apical surface of the cells. The
addition of 20mg/ml decreased BAAV transcytosis activity almost
80% on HAE, and by 50% on MDCKI (Fig. 2B and C). In
contrast, chitotriose did not significantly affect AAV4 transcytosis
(Fig. 2C). In addition to chitotriose, chitin hydrolysate, a crude
mixture of chito-oligomers that has previously been used to block
transcytosis of Ecoli K1, a chitotriose dependent pathogen, was
also tested. Titration experiments on MDCKI cells indicated that
TER was unchanged at concentrations of chitin hydrolysate up to
250mg/ml (data not shown). Addition of 125mg/ml chitin
hydrolysate inhibited ,80% of the BAAV transcytosis but had
no significant effect on the transcytosis of AAV4 (Fig. 2C).
Moreover, addition of heparin sulfate, another charged glycan,
resulted in marginal to moderate (,10% and 60%) increases in
the BAAV and AAV4 transcytosis activity, respectively (Fig. 2C).
The core structure of chitotriose is a b-1-4-linked N-acetyl
glucosamine, which is reportedly bound by several lectins,
including wheat germ agglutinin (WGA) [26]. In competition
experiments, preincubation of MDCKI cells with 30mg/ml of
WGA inhibited 85% of BAAV transcytosis activity but had no
significant effect on AAV4 transcytosis (Fig 2D). Higher
concentrations of lectins resulted in a decrease in TER (data not
shown). A similar level of inhibition was also observed at 10mg/ml
(data not shown). In contrast, dolichos biflorus agglutinin (DBA),
which binds N-acetylgalactosamine, had the opposite effect on
both viruses and resulted in ,50% and 100% increase in
transcytosis for BAAV and AAV4, respectively (Fig. 2D) [27].
Sialic acid linked to gangliosides is important in the transduction of
BAAV [7] and for AAV4, O-linked sialic acid has been shown to
be important for its transduction [7]. To test the role of sialic acid,
and therefore gangliosides in BAAV transcytosis, MDCKI cells
were either preincubated with the maackia amurensis lectin II
(MALII), which binds specifically to sialic acid, or treated with
neuraminidase, which enzymatically removes cell surface sialic
acid, prior to the addition of vector (Fig. 2D). In both cases no loss
Figure 2. Effects of chitotriose, chitin hydrolysate, and lectins on BAAV transduction and transcytosis. (A) BAAV transduction is not
affected by chitotriose. Cos cells plated in 96 well dishes were transduced in serial dilution with either BAAV or AAV4 vector encoding a CMV-eGFP
expression cassette in either the presence or absence of 20mg/ml chitotriose. (B, C) Chitotriose and chitin hydrolysate inhibits BAAV transcytosis.
DNAse resistant particles (DRP) of recombinant BAAV or AAV4, are applied on the upper (apical) side of the monolayer of cells grown on membrane
insert filters (Transwell) either alone or in the presence of chitotriose (20mg/ml), chitin hydrolysate (125mg/ml), or heparin (20mg/ml). Three hours post
incubation, viral DNA was extracted from the basal side medium and quantified by QPCR and expressed as a percent of the amount of vector in the
basal media in the absence of any inhibitors. (B) HAE cells (C) MDCKI cells. N=4. (D) Lectins inhibit BAAV or AAV4 transcytosis. Viruses were incubated
with cells in presence of wheat germ agglutinin WGA 30mg/ml, dolichos biflorus agglutinin (DBA) 30mg/ml, maackia amurensis lectin II (MALII) 30mg/
ml or neuraminidase 0.2mg/ml. Three hours post incubation, viral DNA was extracted and quantified and expressed as a percent of the amount of
vector in the basal media in the absence of any inhibitors. * P,0.05.
doi:10.1371/journal.pone.0009336.g002
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transduction, sialic acid and therefore gangliosides, do not have a
role in BAAV transcytosis. In contrast AAV4 transcytosis was
inhibited by ,60% following both treatments (Fig. 2D). Taken
together these experiments strongly suggest that the interaction of
BAAV with chitotriose and chito-oligomers are important for
BAAV transcytosis and that these interactions are virus specific.
Furthermore, inhibition of BAAV transcytosis on both HAE and
MDCKI epithelial barrier models suggests the vector may use the
same transcytosis pathway on both cell types.
Chitotriose Blocks BAAV Tannic Acid Mediated
Transduction and Virus Entry
Our findings suggested that BAAV, like E. coli K1, requires an
interaction with b-1-4 linked N-acetyl glucosamine for transcytosis
to occur. To confirm that the chitotriose inhibition of transcytosis
is due to its effect on cell entry and not due to the redirection of the
vector to alternative pathways, we tested the effect of chitotriose on
BAAV tannic acid (TA) mediated transduction (Fig. 3A). Previ-
ously we had demonstrated that treatment of the basolateral
surface of cells grown on a Transwell with low concentrations of
TA could block vector egress from the cell [11]. Furthermore, the
internalized particles were redirected to the nucleus resulting in
transduction [11]. In agreement with our earlier observation, the
addition of chitotriose was able to block TA mediated transduction
of BAAV on HAE and MDCKI cells (Fig. 3A and B). 48 hrs post
vector addition, transduction with BAAV/chitotriose vectors
encoding GFP on TA treated HAE or MDCKI cells decreased
3 and 15 fold respectively compared with that of TA controls
(Fig. 3A and B, BAAV TA chitotriose versus BAAV TA). As
expected, BAAV alone was not able to transduce the cells (Fig. 3A,
BAAV).
These observations suggest that the BAAV vector particles are
likely entering the cell via transcytosis and that chitotriose blocks
this entry mechanism. Transcytosis is a complex process and likely
involves multiple interactions with cellular factors. In order to
determine if chitotriose is affecting the entry of BAAV particles
into the cell, qPCR was used to measure the number of
internalized genomes in the TA treated cells either +/2 the
addition of chitotriose (Fig. 3C). After incubation with BAAV
particles +/2 chitotriose the cells were extensively washed and
treated with proteases to remove BAAV particles on the cell
surface followed by isolation of total DNA and quantification by
qPCR. As previously demonstrated, by treating the cells first with
TA to block the egress of the particles, apical administration of
BAAV on MDCKI cells increased the level of vector in the cell by
,3-fold compared with the control samples. However, the
addition of chitotriose reduced the amount of internalized
genomes by 40% compared with the TA only treated samples
(Fig. 3C BAAV). AAV4 has transcytosis activity on MDCKI cells
Figure 3. Chitotriose inhibits BAAV TA mediated transduction and cellular virus entry. (A) Tannic acid was added to the basal medium of
HAE or MDCKI cells while vector was added either alone or in the presence of chitotriose (20mg/ml) to the apical surface. Transduction of cells treated
with BAAV, BAAV and TA or BAAV, TA and chitotriose was observed 48 h post-vector addition by fluorescence microscopy. (B) Fluorescence
comparison. Value of cells treated with BAAV TA +/2 chitotriose was calculated after subtracting fluorescence background from BAAV only treated
cells and expressed as a percent of fluorescence of the BAAV TA treated cells. (C) BAAV internalization in presence of chitotriose. MDCKI cells were
incubated with BAAV or AAV4 in presence of tannic acid with or without chitotriose as above. Four hour post administration, cells were washed
extensively with PBS and non-internalized bound particles were removed by incubating the cells with trypsin and protease K. Total DNA was isolated
from the cells by phenol/chloroform extraction and viral genomes quantified by qPCR using primers specific for the promoter region. * P,0.05.
doi:10.1371/journal.pone.0009336.g003
BAAV, Transcytosis, gp96
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treating the basolateral surface of these cells with TA. In
agreement with our results with BAAV, detection of AAV4
genomes in the TA treated cells also increased (by ,70–100%)
compared with untreated control cells. However, this increase in
internalized particles was not inhibited by addition of chitotriose
but rather resulted in a further increase of ,100% (Fig. 3C
AAV4). Taken together these observations show that chitotriose
inhibits BAAV transcytosis and TA transduction by impeding the
entry phase of transcytosis and further confirms that the AAV4
transcytosis phenomenon is chitotriose independent.
Identification of gp96 As a Receptor for BAAV
Transcytosis
The transcytosis pathway followed by BAAV is very similar to
that reported for E. coli K1. Both are inhibited by WGA lectin,
chitotriose, chitin hydrolysate, treatment of cells with filipin, and it
can occur on in vitro cultures of blood brain barrier (BBB)
endothelial cells [11,25]. Extensive research on E. coli K1
transcytosis has identified a close homolog of gp96 as the protein
receptor responsible for transcytosis across the BBB [24]. Recent
reports suggest that gp96 can also function as a receptor for
Clostridium difficile toxin A transcytosis, Listeria monocytogenes invasion
and Neisseria gonorrhoeae cell attachment [28–30]. gp96 is a member
of the heat shock protein family and localized to the endoplasmic
reticulum where its chaperone function is critical for the proper
folding of many substrates [31]. However, under appropriate
conditions it also can be found on the apical membrane ([28,30]
and P.K. Srivastava personal communication). MDCKI and
Caco-2 cells differ in BAAV transcytosis activity by 3–4-fold [11].
In order to determine if the cellular expression and localization of
gp96 correlated with BAAV transcytosis activity in these cells,
western blots analysis and cell immunofluorescence assays were
performed. Western blots of whole cell lysates from MDCKI and
Caco-2 showed a similar level of gp96 expression (Fig. 4A).
However, confocal immunofluorescent plasma membrane imaging
of cells with an anti-gp96 followed by labeled secondary antibody,
showed a more uniform distribution of gp96 on permissive
MDCKI cells compared with the more weakly permissive Caco-2
cells where it appeared more scattered and in clusters (Fig. 4B).
Quantification of plasma membrane fluorescence for these cells
showed a difference (,3-fold higher) in pixel intensity representing
the gp96 distribution in MDCKI cells compared with Caco-2 cells
consistent with the overall difference in transcytosis activity
(Fig. 4C). This observation suggests that gp96 may be involved
in BAAV transcytosis. To investigate a direct role of gp96 in
BAAV transcytosis, competition experiments using an anti-gp96
antibody or the soluble gp96 extracellular domain were per-
formed. MDCKI cells grown on a Transwell were treated with
either a polyclonal antibody to gp96 or PDGFRa (25 mg/ml), a
receptor for AAV5, as a negative control, prior to the addition of
BAAV or AAV4 vectors. Four hours post incubation with vector,
transcytosis was measured. In contrast to treatment with the anti-
PDGFRa antibody, transcytosis was decreased by 50% following
treatment with the anti-gp96 antibody whereas that of AAV4 was
unaffected (Fig. 5 control, anti-gp96, anti-PDGFRa). Further-
more, the addition of a soluble form of gp96 (25 mg/ml) had a
similar effect on BAAV transcytosis but no significant effect on
Figure 4. gp96 quantification and cell membrane distribution in BAAV transcytosis permissive (MDCKI) and non-permissive (Caco-
2) cells. (A) gp96 western blot from whole cell lysates. GAPDH detection was used as a loading control. (B) Non-permeabilized cells were stained with
anti-gp96 followed by Alexafluor 488 secondary antibody and analyzed by confocal immunofluorescence laser microscopy. (C) Fluorescence
quantification of 10 random fields. * P,0.05.
doi:10.1371/journal.pone.0009336.g004
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the specificity of the gp96 recognition by BAAV and not AAV4.
The above data suggests a direct interaction between BAAV
and gp96. Alternatively, BAAV could be following the same
internalization pathway as gp96. To test for a direct interaction
between BAAV and gp96, a myc tagged version of gp96 was
expressed in 293T cells and purified using anti-myc affinity beads.
The protein coated beads were then used in an immunoprecip-
itation experiment. The gp96 coated beads or control beads
coated with either GFP or a myc-tagged version of the membrane
protein TRPC1 were then incubated with purified BAAV or
AAV4 viral particles. After extensive washing the bound virus was
quantified by qPCR with primers specific for the reporter gene
cassette. Compared with control GFP or TRPC1 beads, a 2–3fold
increase in the amount of bound BAAV was detected when
incubated with the gp96 coated beads (Fig. 6). In contrast, little
difference in AAV4 binding to GFP, TRPC1 or gp96 coated beads
was observed (Fig. 6). This pull down experiment indicates a direct
interaction between BAAV and gp96.
Discussion
The pathogenicity of a virus can be linked to its cell tropism and
its ability to spread through tissue. Indeed, studies with other
parvovirus such as MVM and CPV suggest that mutations that
affect virus:cell interactions can alter pathogenicity, invasiveness,
and host range [32,33]. For many viruses, the first host defenses
that must be overcome are the barrier epithelia that line the lung,
gastrointestinal, or reproductive tract (for review see [4]). To
overcome this obstacle, viral entry through normal signaling and
trafficking pathways present in these cells represent an attractive
target. A number of mechanisms exist in barrier epithelia for
moving macromolecules from the apical to the basolateral surface.
These include paracellular and passive pores routes, nonselective
transcytosis in the fluid phase of vesicles, or selective receptor-
mediated vesicle transcytosis [12]. Despite all these options, most
pathogens are reported to penetrate barrier cell layers via a
receptor-mediated pathway.
Listeria monocytogenes and E. coli K1 are examples of pathogens
that use gp96 for transcytosis across barrier cell layers. Neisseria
gonorrhoeae uses gp96 as an attachment receptor while S. pneumoniae
translocation across a barrier layer via the poly(IgA) receptor
[14,15,28,30,34].
Our previous work suggested that AAV transcytosis occurs via a
receptor mediated pathway that is distinct from the pathway used
for infection [11]. In this study glycan microarray analysis of
BAAV carbohydrate interactions identified an interaction between
BAAV and chitotriose. Competition assays with this carbohydrate
showed that it did not block transduction but did inhibit
transcytosis in vitro. Additionally, western blots, immunoprecip-
itation, and competition experiments were used to link BAAV’s
ability to bind chitotriose (a trimer of b-1-4-linked N-acetyl
glucosamine) with the post-translationally modified glycoprotein
gp96, suggesting that this protein can serve as a receptor for
BAAV transcytosis. The use of AAV4 as a ‘‘negative’’ control
throughout these studies demonstrated the serotype specificity of
the chitotriose and gp96 interactions with BAAV.
Glycan microarrays are powerful tools for identifying interac-
tions with carbohydrates. However, as with any array platform it is
limited to what is printed on the array. We have previously
reported sialic acid containing glycoshingolipids are necessary for
BAAV transduction [7]. Although the chip contains a number of
sialyated carbohydrates and some gangliosides on the array, there
is no binding with these carbohydrates, suggesting either an
interaction with distinct gangliosides not on the array is required
for transduction or an interaction with other molecules is required
to stabilize the interaction with gangliosides. Detection of other
carbohydrate interactions that are critical to BAAV transduction
will require alternative methods of detection or more extended
versions of glycan microarrays.
Like transduction, AAV transcytosis could be a complex
process. Although our data does show a direct interaction between
gp96 and BAAV, the lack of complete inhibition in the presence of
the anti-gp96 antibody and soluble gp96 suggests that other
membrane components not present with the purified recombinant
gp96 used in the immunoprecipitation experiment may contribute
to the interaction. In addition other factors may also be required
for internalization. A multistep interaction process during cellular
entry has been reported for other AAVs. For example, cellular
transduction by AAV2 requires an interaction with a primary
heparan sulfate proteoglycan receptor as well as several co-
Figure 5. BAAV:gp96 competition experiments. Anti gp96, anti
PDGFRa or soluble gp96 extra cellular domain, 25mg/ml, were placed on
the apical surface of MDCKI cells grown on Transwell, prior to the
addition of BAAV or AAV4. Transcytosis activity was measured by QPCR
after 4 h. Values are expressed relative to the control (BAAV or AAV4
alone). * P,0.05.
doi:10.1371/journal.pone.0009336.g005
Figure 6. BAAV:gp96 immuno-precipitation. Anti-myc sepharose
beads previously incubated with cell lysates either of GFP, or myc-
tagged TRPC1 or gp96 transfected cells were then added with BAAV or
AAV4 vector respectively containing the CMV-GFP expression cassette.
After incubation at 4Cu for 1h, beads were extensively washed and
bound virus was quantified by QPCR. Bound vector was calculated as
fold change in bound vector relative to vector bound to GFP beads
alone. n=3. * P,0.05.
doi:10.1371/journal.pone.0009336.g006
BAAV, Transcytosis, gp96
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receptor and hepatocyte growth factor receptor, for cellular
recognition and internalization [35–38].
To date we have identified transcytosis activity in at least 3 AAV
serotypes (AAV4, AAV5 and BAAV) and this phenomenon has
been suggested to occur in AAV8 and AAV9 [11,16–19]. Two
outstanding questions are (I) whether or not this is a process that is
common to all AAVs and (II) whether or not the other AAVs also
use gp96 for this cellular transport process that is independent of
the transduction pathway. Given the sequence divergence,
utilization of distinct receptors for transduction, and our previous
work describing distinct transcytosis profiles on the different AAV
serotypes, it is possible that each virus will use a distinct
transcytosis pathway if they have transcytosis activity. Indeed the
data presented for AAV4 in this paper suggests that sialic acid is an
important carbohydrate in its transcytosis pathway. Analysis of the
chitotriose/gp96 binding site on BAAV will lead to a better
understanding of the transcytosis activity in the lifecycle of the
AAVs and the potential to provide information that could be
exploited for new applications of AAV gene transfer vectors, such
as the engineering of vectors which could navigate the blood brain
barrier.
Materials and Methods
Cell Cultures, Vector Construction, Preparation, and
Quantification
293T (human kidney) and cos cells were maintained in
Dulbecco’s modified Eagle’s medium supplemented with 10%
fetal bovine serum (FBS). The media contained 2 mM L-
glutamine, 100 U of penicillin/ml, and 0.1 mg of streptomycin/
ml. Cells were maintained at 37uC under a 5% CO2 humidified
atmosphere.
Recombinant BAAV, BAAV-HA, AAV4-HA, and AAV4
viruses expressing eGFP were produced using a four-plasmid
procedure as previously described [8]. Briefly, semiconfluent 293T
cells were transfected by calcium phosphate with four plasmids: an
adenovirus helper plasmid (pAd12) containing the VA RNA and
coding for the E2 and E4 proteins; two AAV helper plasmids
containing the AAV2 rep and AAV specific cap genes, respectively,
and a vector plasmid containing AAV2 inverted terminal repeats
flanking an eGFP expression cassette. Forty-eight hours post-
transfection the cells were harvested by scraping into TD buffer
(140 mM NaCl, 5 mM KCl, 0.7 mM K2 HPO4, 25 mM Tris–
HCl {pH 7.4}) and the cell pellet was collected by low-speed
centrifugation. Cells were lysed in TD buffer by three cycles of
freeze–thaw. The clarified lysate (obtained by further low-speed
centrifugation) was treated with 0.5% deoxycolic acid (DOC) and
100 U/ml DNase (Benzonase) for 30 min at 37uC. Then the virus
was purified using CsCl gradients. Particle titers were determined
by qPCR. Amplification was detected using an ABI 7700 sequence
detector (ABI). Specific primers for CMV were designed by using
the Primer Express program (ABI): CMV forward 59-CATC-
TACGTATTAGTCATCGCTATTACCAT-39, CMV reverse
59-TGGAAATCCCCGTGAGTCA-39. Following denaturation
at 96uC for 10 min, cycling conditions were 96uC for 15 s, 60uC
for 1 min for 40 cycles. The viral DNA in each sample was
quantified by comparing the fluorescence profiles with a set of
DNA standards. The rAAV particle titers were 1–5610
12 DNAse
resistant particles (DRP) per ml.
The HA epitope tag (YPYDVPDYA) was added to BAAV
after amino acid 137 in the VP1 open reading frame to create
BAAV-HA using a site directed mutagenesis kit (Stratagene).
T h ef o l l o w i n gp r i m e r sw e r eu s e d :F o r w a r d5 9 gagacgccgga-
taaaacgtacccatacgacgttccagactacgcagcgcctgcggcaaaaaagaggcc 39
Reverse 59ggcctcttttttgccgcaggcgctgcgtagtctggaacgtcgtatgggtacg-
ttttatccggcgtctc 39. The presence of the tag into the clone was
verified by sequencing. This modification provided an antigenic
epitope for BAAV detection in glycan microarray screening used
to identify carbohydrates that bind this virus as described below.
Glycan Microarray
BAAV-HA particles were produced as described above and
concentrated to a titer of ,1610
14 vg/ml. The concentrated virus
was then dialyzed into a Tris buffer (Tris pH7.5 w/150 mM
NaCl) and used to probe a printed glycan array (PA V2) following
procedures developed by cores D and H of the Consortium for
Functional Glycomics (CFG; an NIH National Institute of General
Medical Sciences initiative (http://www.functionalglycomics.org/
static/consortium/resources/resourcecoreh.shtml) for identifying
specific carbohydrate binding partners for protein and viral lectins
[39]. Briefly, a printed slide containing 264 glycans was incubated
with AAV particles (at 200 mg/ml), and overlaid with a FITC
conjugated anti-HA tag (Molecular Probes Invitrogen) at 5mg/ml.
The fluorescence intensity was detected using a ScanArray 5000
(Perkin-Elmer Inc.) confocal scanner. The image was analyzed
using the IMAGENE image analysis software (Bio- Discovery, El
Segundo, CA). The data were plotted using the Microsoft EXCEL
software. NCBI accession number GSE17443 is MIAME
compliant.
Epithelial Barrier Cell Models
Caco-2, and MDCKI cells were grown at 37uC, in 5% CO2 in
DMEM containing 10% FBS, 1% Pen/Strep (Biosource, CA,
USA). Human primary airway epithelia cells (HAE) were
purchased from Lonza (MD, USA) or Promocell (Heidelberg,
Germany) and were grown at 37uC, 5% CO2 in medium supplied
by the cell provider. HAE cells were expanded and differentiation
was induced as previously described [40] the generation of cell
barrier models for transcytotic assay were carried out as previously
described [11]. Briefly, all cell types were allowed to establish
monolayers on 0.4-m pore size polycarbonate filters in 6 or 12 mm
Transwell chambers (Costar, MA, USA) and the integrity of cell
monolayers, polarization, and formation of tight junctions were
tested by measuring the Transepithelial Electrical Resistance
(TER) using a volt/ohm meter (Millicel; Millipore, MA, USA) in
an electrode chamber (EVOV; WPI, FL, USA). Only filters of cell
monolayers that displayed the required TER were used for the
AAV transcytosis assay, i.e. MDCKI, 2000 V/cm
2; Caco-2 200–
300 V/cm
2, HAE ,1000 V/cm
2, as previously published
[11,12,40,]. As previously reported, no movement of particles
across the membrane was detected on empty Transwells
confirming the seal of the chamber [11]. All experiments with
HAE cells were performed on air–liquid interface cultures.
BAAV Transduction Assay
cos cells were plated in 96 well dishes and incubated, in serial
dilution, with either BAAV or rAAV4 vector encoding a CMV-
eGFP expression cassette in either the presence or absence of




8 DRP of BAAV or rAAV4, suspended in 50 mlo f
DMEM, were placed on the upper (apical) side of the monolayer
of cells grown on 6 mm membrane insert filters (Transwell,
Costar) either alone or in the presence of chitotriose or heparin.
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added to the apical surface. 12 mm insert filters were the
membrane surface is 3 fold larger, medium and virus were
increased, accordingly. After 3 h of incubation, the medium in the
lower (basal) side of the Transwell was collected and tested for the
presence of transcytosed rAAV DNA. Viral DNA was extracted
from 200 ml of medium from the basolateral side of the Transwell
using the DNeasy Mini Spin Column Kit (Qiagen, CA, USA) and
quantified by qPCR as previously described. In tannic acid (TA)
mediated transduction experiments medium containing 0.5% TA
(Polysciences, PA, USA) was placed on the basolateral side of the
Transwell inserts while BAAV was placed on the apical side with
or without chitotriose. Transduction was observed 48 h post-
vector addition by fluorescence microscopy. In carbohydrate
competition experiments, chitotriose, chitin hidrolysate (Vector-
labs), heparin (Sigma) were incubated with BAAV or AAV4
10 min at 4uC prior the addition to the apical side of the cells. In
competition experiments, lectins (Vectolabs), neuraminidase
(Prozyme), anti-gp96 (Stressgen) or anti-PDGFRa (Santa Cruz)
were added on the apical side of MDCKI cells 10 min prior to the
addition of BAAV or AAV4. Whereas, soluble gp96 receptor
(Stressgen) was incubated for 10 min with virus prior to cell
incubation. Three hrs post addition transcytosed virus was
quantified as described above.
BAAV Internalization
Basolaterally TA treated MDCKI cells were incubated with
either BAAV or AAV4 with or without chitotriose as described
above. Four h post administration, cells were washed extensively
with PBS and non-internalized bound particles were removed by
incubating the cells with 0.05% trypsin-EDTA (Gibco) and
0.4 mg/ml protease K (Qiagen) until cells were detached from
each other and from Transwell filters. Cells were washed three
times with PBS, total DNA was isolated from the cells by phenol/
chloroform extraction, and viral genomes quantified by qPCR
using CMV primers.
Western Blot Analysis for gp96
5610
5 MDCKI or Caco-2 cells grown on Transwell were lysed
with 2% SDS containing 0.25 U benzonase (Sigma) and 1:100
dilution of protease cocktail inhibitors (Sigma). Cell lysate was
centrifuged at 11000g for 2 min to remove cell debris, aliquoted,
and stored at 220 C. 50mg/lane of cell lysate was run on a 12%
Bis-Tris gel (Invitrogen) and transferred using a semi-dry
apparatus (Biorad, Richmond CA) to nitrocellulose membrane
for 1 h at 15 volts. The membrane was blocked for 30 min in 5%
milk/TBST (Tris Buffered Saline with 0.05% Tween20), then
incubated with anti-gp96 (Santa Cruz) (1:100 dilution as per
manufacturer’s protocol) in 5% milk/TBST followed by incuba-
tion with anti-mouse secondary antibody (1:5000 dilution,
Amersham) in 5% milk/TBST. All washes were carried out in
TBST. The bands were visualized using ECL Chemiluminescent
Substrate Reagent (Amersham). GAPDH detection was used as a
loading control.
gp96 Cell Membrane Distribution
MDCKI or Caco-2 cells grown on Transwell were fixed in 2%
formaldehyde/PBS for 10–12 min. Non-permeabilized cells were
probed with anti-gp96 (Santa Cruz) in 10% FBS in PBS/0.02%
sodium azide for 1 h followed by a goat anti-rabbit Alexafluor 488
(Molecular Probes, Invitrogen) secondary antibody in 10% FBS in
PBS/0.02% sodium azide for 1 h and analyzed by confocal
immunofluorescence laser microscopy. Fluorescence quantifica-
tion of 10 random fields was obtained using Volocity software
(Improvision, Waltham, MA, USA).
gp96/BAAV Immunoprecipitation
293 cells were transfected with gp96-myc (a gift from
Christopher Nicchitta), TRPC1-myc (a gift from Biman Paria),
or GFP expression plasmids using Lipofectamine 2000 (Invitrogen)
according to the vendor’s protocol. Forty-eight hrs post transfec-
tion, cells expressing gp96, TRCP1, or GFP were lysate in M-Per
reagent (Pierce, Rockford, IL) and immunoprecipitated (IP) using
the Mammalian c-Myc Tag IP/Co-IP kit (Pierce, Rockford, IL).
Anti-myc agarose beads previously incubated with cell lysates
either of GFP, TRPC1 or gp96 myc tagged transfected plasmids
were then mixed with 10
8 DRP of BAAV or AAV4 vector
containing the CMV-GFP expression cassette. After incubation at
4Cu for 1 h, the beads were extensively washed with TBS-T buffer
in spin columns. The DNA of bound vector was extracted by
phenol/chloroform and quantified by qPCR. Vector bound to the
anti-myc beads was calculated as fold change in bound vector
relative to vector bound to GFP beads alone. These experiments
were done in triplicate (n=3).
Statistics
All data are expressed as means +/2 standard error
measurement (SEM). Unpaired Student’s t-test was used to assess
the significant difference between groups. P values ,0.05 were
considered significant.
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